Skip to main content

$5.19 0.12 (2.37%)

High

$5.29

Low

$5.12

Trades

1,945

Turnover

$3,576,754

Volume

686,116
30 June 2023 at 4:10pm
Register to track AVH and receive email alerts.
Subject
AVH Article: Spray-on skin hopeful Avita Medical nosedives 19pc on revenue miss

AVH Ann: Notice under section 708A(5)(e) of the Corporations Act

AVH Ann: Notification regarding unquoted securities - AVH

AVH Ann: AVITA Medical Submits FDA PMA Supplement for RECELL GO

AVH Ann: Form 8-K

AVH Ann: AVITA Medical Rejoins the Russell 3000 Index

AVH Ann: Notice under section 708A(5)(e) of the Corporations Act

AVH Ann: Notification regarding unquoted securities - AVH

AVH Ann: Notification regarding unquoted securities - AVH

AVH Ann: Notice under section 708A(5)(e) of the Corporations Act

AVH Ann: Notification regarding unquoted securities - AVH

AVH Ann: AVITA Medical Announces FDA Approval of RECELL for Vitiligo

AVH Ann: AVITA Medical Appointment of Chief Financial Officer

AVH Ann: Change of Director's Interest Notice - Suzanne Crowe

AVH Ann: Change of Director's Interest Notice - Robert McNamara

AVH Ann: Change of Director's Interest Notice - Louis Panaccio

AVH Ann: Change of Director's Interest Notice - Jeremy Curnock Cook

AVH Ann: Change of Director's Interest Notice - Jan Stern Reed

AVH Ann: Change of Director's Interest Notice - James Corbett

AVH Ann: Change of Director's Interest Notice - Cary Vance

AVH Ann: Notification regarding unquoted securities - AVH

AVH Ann: Notification regarding unquoted securities - AVH

AVH Ann: Statement of CDIs on issue - AVH

AVH Ann: AVITA Medical Receives FDA Approval for Full-Thickness Skin

AVH Ann: Results of 2023 Annual Meeting of Stockholders - Updated

AVH Ann: Results of 2023 Annual Meeting of Stockholders

AVH Ann: Statement of CDIs on issue - AVH

AVH Ann: 2023 ASM Chairman Script

AVH Ann: 2023 Annual Meeting of Stockholders Presentation

AVH Ann: Notification of cessation of securities - AVH

AVH Ann: Notice under section 708A(5)(e) of the Corporations Act

AVH Ann: Notification regarding unquoted securities - AVH

AVH Ann: Notification of cessation of securities - AVH

AVH Ann: AVITA Medical Reports in U.S. Dollars

AVH Ann: Q1 2023 Investor Presentation

AVH Ann: Notification regarding unquoted securities - AVH

AVH Ann: AVITA Medical to Host Investor Webinar Briefing

AVH Ann: Quarterly Financial Report Form 10-Q

AVH Ann: AVITA Medical Reports Financial Results, Affirms FY Guidance

AVH Ann: Statement of CDIs on issue - AVH

AVH Ann: Notification of cessation of securities - AVH

AVH Ann: AVITA Medical to Announce First Quarter 2023 Results

AVH Ann: Form S-3 Registration Statement

AVH Ann: Sales Agreement

AVH Ann: Proposed issue of securities - AVH

AVH Ann: Definitive Proxy Statement

AVH Ann: AVITA Medical Announces Update to Automation Device

AVH Ann: Statement of CDIs on issue - AVH

AVH Ann: Notification of cessation of securities - AVH

AVH Ann: Initial Director's Interest Notice - Robert McNamara

Register to track AVH and receive email alerts.